Submit your email to push it up the queue
Copan Diagnostics, Inc., a leading player in the microbiology and molecular diagnostics industry, is headquartered in the United States. Founded in 1983, the company has established itself as a pioneer in the development of innovative sample collection and transport systems, particularly in the fields of clinical diagnostics and environmental testing. With a strong presence in North America and Europe, Copan is renowned for its unique products, such as the Flocked Swab® and the Copan ESwab™, which enhance specimen collection and preservation. These advancements have positioned Copan as a trusted partner for laboratories worldwide, contributing to improved patient outcomes and streamlined workflows. Recognised for its commitment to quality and innovation, Copan Diagnostics continues to lead the market with cutting-edge solutions that address the evolving needs of healthcare professionals and researchers alike.
How does Copan Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Copan Diagnostics, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Copan Diagnostics, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary and does not inherit emissions data from a parent organisation. Consequently, there are no documented reduction targets or climate pledges available at this time. As a current subsidiary, Copan Diagnostics, Inc. may align with broader industry standards and practices regarding climate commitments, but specific initiatives or targets have not been disclosed. The lack of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, it is essential for companies like Copan Diagnostics to establish clear climate commitments and reduction targets to contribute to global efforts in mitigating climate change.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Copan Diagnostics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.